<DOC>
	<DOCNO>NCT00631124</DOCNO>
	<brief_summary>Investigation new pill contain estrogen progestin order monitor inhibition ovulation young healthy female 3 treatment cycle</brief_summary>
	<brief_title>A Study Evaluate Inhibition Ovulation Two Oral Estrogen/Progestogen Regimens Healthy , Young Females Over Period 3 Treatment Cycles</brief_title>
	<detailed_description />
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy female volunteer , Age 18 35 year Contraindications use combine ( estrogen/progestogen ) contraceptive ( e.g . history venous/arterial thromboembolic disease ) Regular intake medication Clinically relevant finding ( ECG , blood pressure , physical , gynecological examination , laboratory examination ) Anovulatory pretreatment cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Contraception</keyword>
</DOC>